UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Looking for extra income? Discover various work from home side hustles that can help you earn money while balancing your schedule!
12,982 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Bitcoin revives after a tough stretch as geopolitical risk cools and oil markets settle. Traders monitor ETF momentum...
A major family-office investor has increased its position in Middleby as the company prepares a spin-off. This move o...
U.S. authorities have opened a preliminary inquiry into whether Binance facilitated Iran sanctions violations. The de...
As voters head toward the 2026 U.S. midterms, traders see a repeatable pattern: election-year volatility in stocks an...
A new look at how digital money, especially stablecoins, is shaping illegal gold markets. Learn why stablecoins have ...
Orchid Island Capital pays a near 20% yield, but the story behind it is complex. This piece breaks down how the payou...
Five AI models were asked whether Bitcoin would top $100,000 again in 2026. Four forecast a rebound above that level,...
AI-powered venture activity in Q4 2025 shows a notable revival in healthtech, cybersecurity, biotech, and enterprise ...
A fresh look at Toyota, Brunswick, and Foresight ranks the best mobility stocks based on earnings power, cash flow, a...
PayPal is extending the reach of its USD-backed PYUSD stablecoin to 70 international markets. With PYUSD supply surpa...
Jack Schlossberg issues a blunt warning to America’s CEOs: treat culture and AI-driven shifts as core business risks,...